Drug news
CHMP recommends Mirvaso for Rosacea-Galderma
Galderma has received a positive opinion from the CHMP recommending the granting of a marketing authorization of Mirvaso (brimonidine tartrate 3 mg/g gel) for the symptomatic treatment of facial erythema of Rosacea in adult patients.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.